CLCN3 and central nervous system cancer: A MTT assay showed that knockdown of CLC-3 did not significantly change the growth rate of glioma cells at 20 h (Supplementary Figure 1), however, knockdown of CLC-3 significantly inhibited the migration of U87MG cells (Figure 2B).